Quest Diagnostics (DGX) Receivables - Net (2016 - 2025)
Historic Receivables - Net for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to $1.5 billion.
- Quest Diagnostics' Receivables - Net rose 581.4% to $1.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year increase of 581.4%. This contributed to the annual value of $1.3 billion for FY2024, which is 776.86% up from last year.
- According to the latest figures from Q3 2025, Quest Diagnostics' Receivables - Net is $1.5 billion, which was up 581.4% from $1.4 billion recorded in Q2 2025.
- Quest Diagnostics' Receivables - Net's 5-year high stood at $1.5 billion during Q3 2021, with a 5-year trough of $1.2 billion in Q4 2022.
- Over the past 5 years, Quest Diagnostics' median Receivables - Net value was $1.3 billion (recorded in 2024), while the average stood at $1.3 billion.
- In the last 5 years, Quest Diagnostics' Receivables - Net soared by 4218.11% in 2021 and then crashed by 1689.85% in 2022.
- Over the past 5 years, Quest Diagnostics' Receivables - Net (Quarter) stood at $1.4 billion in 2021, then fell by 16.9% to $1.2 billion in 2022, then increased by 1.26% to $1.2 billion in 2023, then increased by 7.77% to $1.3 billion in 2024, then rose by 11.66% to $1.5 billion in 2025.
- Its Receivables - Net was $1.5 billion in Q3 2025, compared to $1.4 billion in Q2 2025 and $1.4 billion in Q1 2025.